Invention Application
- Patent Title: SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF
-
Application No.: PCT/AU2019/051194Application Date: 2019-10-30
-
Publication No.: WO2020000065A2Publication Date: 2020-01-02
- Inventor: TOOP, Hamish , PAUL, Dharam , SINGH, Rajinder , SMITH, Erin , BAZZINI, Patrick , CONTRERAS, Jean-Marie , MORICE, Christophe , SCHAEFFER, Laurent , MICHAUT-SIMON, Celine , CHERY, Florence , GARRIDO, Fabrice
- Applicant: BIONOMICS LIMITED
- Applicant Address: 31 Dalgleish Street Thebarton, South Australia 5031 AU
- Assignee: BIONOMICS LIMITED
- Current Assignee: BIONOMICS LIMITED
- Current Assignee Address: 31 Dalgleish Street Thebarton, South Australia 5031 AU
- Agency: DAVIES COLLISON CAVE PTY LTD
- Priority: AU2019900992 20190325
- Main IPC: C07D401/14
- IPC: C07D401/14
Abstract:
The present disclosure relates generally to compounds useful for the treatment and/or enhancement of cognitive function and negative symptoms associated with central nervous system disorders where the circuitry involving fast spiking PV+ interneurons and the production of cortical gamma oscillations is disrupted. The subject disclosure enables the manufacture of medicaments as well as compositions containing same for use in methods of therapy and prophylaxis of cognitive dysfunction and negative symptoms.
Public/Granted literature
- WO2020000065A3 SUBSTITUTED-N-HETEROARYL COMPOUNDS AND USES THEREOF Public/Granted day:2020-01-02
Information query
